Ac immune reports progress for therapeutic programs targeting the nlrp3 inflammasome pathway

Highly potent in vivo anti-inflammatory activity demonstrated for novel small molecule nlrp3 inhibitors
ACIU Ratings Summary
ACIU Quant Ranking